27 news items
Page 2 of 2
9lfja45net1ef7fkpoq1dwfk5jikfi6ka7xavie7spb5xw4axhpab
BMY
19 Mar 24
Bristol Myers's CAR-T cell therapy Abecma. The briefing documents noted that Abecma was linked to earlier deaths, citing late-stage clinical trial
g91selk22bps4jo7o9w940515gf3jn4 puep0n
BMY
TSVT
15 Mar 24
) of patients receiving ABECMA, including Grade 3 in 4% (5/127) of patients. One patient had ongoing Grade 2 neurotoxicity at the time of death. Two
cayfk3evv9beyd 0w8xf51fd3
BMY
14 Mar 24
CRS in 4.1% of patients. One patient had fatal CRS and 2 had ongoing CRS at time of death. The median time to onset was 5 days (range: 1 to 15 days
tgfk6opovxi6kpi l6bvbli1c479xl13csjuhnv73ma1e45jv8f5
BMY
JNJ
LEGN
13 Mar 24
assessment of ciltacabtagene-autoleucel (cilta-cel) for the proposed indication.
Specifically, is the risk of early death associated
4l0bq1oaa42o5eoy9s2n9p
BMY
7 Mar 24
with Opdivo in combination with cisplatin and gemcitabine reduced the risk of death by 22%, demonstrating a median OS of 21.7
02qlu52w1tq6vdm361dr5e f9eq90
AZN
BMY
JNJ
5 Mar 24
to control the epidemic. Drug overdose was behind 112,000 deaths in 2023, with rates that remain way above pre-pandemic numbers. Although
kibjsfkcqql2r5ar35doydbsx
BMY
29 Feb 24
are immunocompromised, and that usually leads to death or severe disability.
PML has been reported in patients